Bilimsel çalışmalar

Prof. Dr. Johan Joseph Marıa Catharına Hubertus Delarosette

707 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön

  1. J.J.M.C.H. de la Rosette, G.Alivizatos, S. Madersbacher, M. Perachino, D. Thomas, F. Desgrandchamps, M. de Wildt. EAU Guidelines on Benign Prostatic Hyperplasia (BPH). Eur Urol 2001; (40): 256-263.

    Kaynak: medipol.com.tr profil sayfası

  2. Y. Xue, G. Sonke, C. Schoots, J. Schalken, A. Verhofstad, J.J.M.C.H. de la Rosette, F. Smedts. Proliferative activity and branching morphogenesis in the human prostate: a closer look at pre- and postnatal prostate growth. The Prostate 2001; (49): 132-139.

    Kaynak: medipol.com.tr profil sayfası

  3. J.J.M.C.H. de la Rosette. Introduction. Eur Urol 2001; 40(1).

    Kaynak: medipol.com.tr profil sayfası

  4. A.L. Hoffmann, J.J.M.C.H. de la Rosette, H. Wijkstra. Intraprostatic temperature monitoring during transurethral microwave thermotherapy: status and future developments. J Endourol 2001; 14(8): 637-642.

    Kaynak: medipol.com.tr profil sayfası

  5. D.L. Floratos, J.J.M.C.H. de la Rosette. The future role of microwave therapy in benign prostatic hyperplasia. Urol Integr Invest 2001; (6-3): 215-223.

    Kaynak: medipol.com.tr profil sayfası

  6. M.P. Laguna, L.A. Kiemeney, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. Baseline prostatic specific antigen does not predict the outcome of high energy transurethral microwave thermotherapy. J Urol 2002: 1727-1730.

    Kaynak: medipol.com.tr profil sayfası

  7. G.S. Sonke, C. Robertson, A.L.M. Verbeek, W.P.J Witjes, J.J.M.C.H. de la Rosette, A method for estimating within-patient variability in maximum urinary flow rate adjusted for voided volume. Urology 2002; (59-3): 368-372.

    Kaynak: medipol.com.tr profil sayfası

  8. J.J.M.C.H. de la Rosette, B.B.M. Kortman, C. Rossi, G.S. Sonke, D.L. Floratos, L.A.L.M. Kiemeney. Long-term risk of retreatment in patients using alpha-blockers for lower urinary tract symptoms. J Urol 2002; (167): 1734-1739.

    Kaynak: medipol.com.tr profil sayfası

  9. J. Eckersley, J.P.M. Sedelaar, M.J. Blomley, H. Wijkstra, N.M. DeSouza, D.O. Cosgrove, J.J.M.C.H. de la Rosette. Quantitative microbubble enhanced transrectal ultrasound as tool for monitoring hormonal treatment of prostate cancer. Prostate june 2002 51(4): 256-267.

    Kaynak: medipol.com.tr profil sayfası

  10. J.J.M.C.H. de la Rosette, D.K.E. van der Schoot, F.M.J. Debruyne. Recent developments in guidelines on benign prostatic hyperplasia. Current Opinion in Urology 2002; (12): 3-6.

    Kaynak: medipol.com.tr profil sayfası

  11. J.J.C.M.H. de la Rosette F. Smedts, C. Schoots, H. Hoek, P. Laguna. Changing patterns of keratin expression characterize functional maturation in developing human bladder. J Urol 2002; 168(2): 709-717.

    Kaynak: medipol.com.tr profil sayfası

  12. W.P.J. Witjes, J.J.M.C.H. de la Rosette, A. van den Berg-Segers, D. Colongo, G. Koch, A.R. Zlotta, A. Colau, M.J.A.M. de Wildt, H. Wijkstra. Computerised assessment of maximum urinary flow: an efficient, consistent and valid approach. Eur Urol 2002 41(2): 206-213.

    Kaynak: medipol.com.tr profil sayfası

  13. B. Djavan, J.C. Nickel, J.J.M.C.H. de la Rosette, P. Abrams. The Urologist view of BPH progression: Results of an international survey. Eur. Urol 2002; 41(5): 490-496.

    Kaynak: medipol.com.tr profil sayfası

  14. J.J.M.C.H. de la Rosette, C.C. Abbou, J. Rassweiler, M.P. Laguna, CC. Schulman. Laparoscopic radical prostatectomy: a European virus with global potentials. Arch. Esp. Urol. 2002; 55(6): 603-609.

    Kaynak: medipol.com.tr profil sayfası

  15. P.C. Soeverein, R.M.C. Herings, A.J. Man in ‘t Veld, J.J.M.C.H. de la Rosette, R.D.T. Farmer, H.G.M. Leufkens. Study of the association between ischemic heart disease and use of alpha-blockers and finasteride indicated for the treatment of benign prostatic hyperplasia. Eur. Urol. 2002; 42: 254-261.

    Kaynak: medipol.com.tr profil sayfası

  16. J. Veltman, T. Goossen, M.P. Laguna, H. Wijkstra, J.J.M.C.H. de la Rosette. New technical improvements for TRUS in diagnosis of prostate cancer. Eur Urol. Supplements 1; 2002; 1(6): 8-14.

    Kaynak: medipol.com.tr profil sayfası

  17. J. Vanderkerken, J.J.M.C.H. de la Rosette, M.P. Laguna, F.M.J. Debruyne. How and when to take prostate biopsies. Eur. Urol. Supplements 1; 2002; 1(6): 15-20.

    Kaynak: medipol.com.tr profil sayfası

  18. J.P.M. Sedelaar, G.J.L.H. van Leenders, T.E.B. Goossens, C.A. Hulsbergen-van der Kaa, N.P. van Adrichem, H. Wijkstra, J.J.M.C.H. de la Rosette. The value of contrast ultrasonography in the detection of significant prostate cancer: correlation with radical prostatectomy specimens. Prostate 2002; 53: 246-253.

    Kaynak: medipol.com.tr profil sayfası

  19. P.C. Souverein, R.M.C. Herings, J.A. Erkens, J.J.M.C.H. de la Rosette, H.G.M. Leufkes, H.G.M. Leufkens. Drug treatment of benign prostatic hyperplasia and hospital admission for BPH-related surgery. Eur Urol. 2003; 43: 528-534.

    Kaynak: medipol.com.tr profil sayfası

  20. A.L. Hoffmann, M.P. Laguna, J.J.M.C.H. de la Rosette, H. Wijkstra. Quantification of Prostate shrinkage after microwave thermotherapy: a comparison of calculated cell-kill versus 3D transrectal ultrasound planimetry. Eur. Urol. 2003; 181-187.

    Kaynak: medipol.com.tr profil sayfası

  21. M. Emberton, G. Andriole, J.J.C.M.H. de la Rosette, B. Djavan, K. Hofner, V. Navarrete, J. Nordling, C. Roehrborn, C. Schulman, P. Teillac, A. Tubaro, C. Nickel. BPH: A progressive disease of the ageing male. Urology. 2003; 61: 267-273.

    Kaynak: medipol.com.tr profil sayfası

  22. S. Gravas, M.P. Laguna, J.J.M.C.H. de la Rosette. Thermotherapy and thermoablation for BPH. Curr. Opnion Urol. 2003; 13: 45-49.

    Kaynak: medipol.com.tr profil sayfası

  23. J.J.M.C.H. de la Rosette, M.P. Laguna, S.Gravas, M.J.A.M. de Wildt. Transurethral Microwave Thermotherapy: the 'gold standard' for minimal invasive therapies in patients with Benign prostatic Hyperplasia (BPH). J. Endourol 2003; 4: 245- 251

    Kaynak: medipol.com.tr profil sayfası

  24. M.G. Harisinghani, J. Barentsz, P.F. Hahn, W.M. Deserno, S. Tabatabaei, C.H. van der Kaa., J.J.M.C.H. de la Rosette, R. Weissleder. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med. 2003; 348(25):2491-9.

    Kaynak: medipol.com.tr profil sayfası

  25. S. Gravas, M.P. Laguna, P.J. van Hest, J.J.M.C.H. de la Rosette. Efficacy and safety of intraprostatic temperature controlled microwave thermotherapy in patients with benign prostatic hyperplasia: Results of a porspective, open label, single center study with 1-year follow up. J. Endourol. 2003; 17: 425-430.

    Kaynak: medipol.com.tr profil sayfası

  26. T.M. de Reijke, H.P. Beerlage, A.J. Hendrikx, J.J.M.C.H. de la Rosette, C.A. Mc.Killop. Prostate cancer: the right treatment for the right patient. Amsterdam 17 -18 Januari 2001. Prostate Cancer Prostatic Dis. 2003; 6(2): 193-197.

    Kaynak: medipol.com.tr profil sayfası

  27. B.W. Lagerveld, M.P. Laguna, J.J.M.C.H. de la Rosette. Long-term results after extrernal beam radiation therapy for T1-T2 localixes prostate cancer. Curr. Urol. Rep. 2003; 4:240-247.

    Kaynak: medipol.com.tr profil sayfası

  28. D.L. Floratos, M.P. Laguna, L.A.L.M. Kiemeney, F.M.J. Debruyne, J.J. M.C.H. de la Rosette. Transurethral Resection versus Microwave Thermotherapy of the Prostate. A Cost-Consequences Analysis. BJU 2003; 92: 713-718.

    Kaynak: medipol.com.tr profil sayfası

  29. C.A. Mochtar, L.A.L.M. Kiemeney, M.M. van Riemsdijk, G.S. Barnet, M.P. Laguna, F.M.J. Debruyne, J.J.M.C.H. de la Rosette. PSA as an estimator of prostate volume in the management of patients with symptomatic BPH. Eur. Urol. 2003; 44: 65-700.

    Kaynak: medipol.com.tr profil sayfası

  30. B.B.M. Kortmann, D.L. Floratos, L.A.L.M. Kiemeney, H. Wijkstra, J.J.M.C.H. de la Rosette. Urodynamic Effects of Alpha-Adrenoceptor Blockers: A Review of Clinical Trials. Urology 2003; 62:1-9.

    Kaynak: medipol.com.tr profil sayfası

  31. T.E.B. Goossen, J.J.M.C.H. de la Rosette, C.A. Hulsbergen-van de Kaa, H. Wijkstra. The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 2003. 43(2): 124-131.

    Kaynak: medipol.com.tr profil sayfası

  32. M.R. Engelbrecht, H.J. Huisman, R.J.R. Laheij, G.J. Jager, G.J.L.H. van Leenders, C.A. Hulsbergen-van de Kaa, J.J.M.C.H. de la Rosette, J.G. Blickman, J.O. Barentsz. Discrimination of prostate cancer from peripheral zone and central zone gland tissue using dynamic contrast-enhanced MR imaging. Radiology. 2003. 229(1): 248-54.

    Kaynak: medipol.com.tr profil sayfası

  33. J.P.M. Sedelaar, J.J.M.C.H. de la Rosette, F.M.J. Debruyne. Progress in imaging of the prostate gland. Curr Urol Rep. 2003. 4(1):1-2.

    Kaynak: medipol.com.tr profil sayfası

  34. M. Marberger., R. Harkaway, J.J.M.C.H. de la Rosette. Optimising the medical management of BPH. Eur. Urol. 2004; 45: 411-419.

    Kaynak: medipol.com.tr profil sayfası

  35. C. Huidobro, M. Bolmsjö, T. Larson, J.J.M.C.H. de la Rosette, L. Wagrell, S. Schelin, T. Gorecki, A. Mattiasson. Evaluation of Prostalund coretherm microwave theromotherapy with histo-pathology, MRI and temperature mapping. J.Urol. 2004; 171:672-678.

    Kaynak: medipol.com.tr profil sayfası

  36. T. Horn, B.B. Kortmann, F. Smedts, J. Nordling, L.A. Kiemeney, J.J.M.C.H. de la Rosette. Routine bladder biopties in men with bladder outlet obstruction? Urol. 2004; 63(3): 451-456.

    Kaynak: medipol.com.tr profil sayfası

  37. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, A. Verhofstad, A. van Leenders, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentz, Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)-H MR spectroscopic imaging of human prostate cancer. J. Magn Reson Imaging. 2004; 20(2): 279-287.

    Kaynak: medipol.com.tr profil sayfası

  38. C. Roehrborn, J.J.M.C.H. de la Rosette, G. Andriole. The utility of serial PSA measurements for the diagnosis of prostate cancer is preserved in men treated with the dual 5α-reductase inhibitor dutasteride.

    Kaynak: medipol.com.tr profil sayfası

  39. M.C. Michel, J.J.M.C.H. de la Rosette. Efficacy and safety of tamsulosin in the treatment of urological diseases. Ashley Pub. Expert opinion Pharmacother. 2004; 5:1-10.

    Kaynak: medipol.com.tr profil sayfası

  40. N. Naderi, C.A. Mochtar, J.J.M.C.H. de la Rosette. Real life practice in the management op BPH. Curr. Opin Urol 2004; 14: 41-44.

    Kaynak: medipol.com.tr profil sayfası

  41. P. Bhowmick, J.E. Coad, S Bhowmick, J.L. Pryor, T. Larson, J.J.M.C.H. de la Rosette, J.C. Bischof. In vitro assessment of the efficacy of thermal therapy in human benign prostatic hyperplasia. Int. J. Hyperthermia. 2004; 20(4): 421-439.

    Kaynak: medipol.com.tr profil sayfası

  42. F.A. van Dorsten, M. van der Graaf, M.R. Engelbrecht, G.J. van Leenders, A. Verhofstad, M. Rijpkema, J.J.M.C.H. de la Rosette, J.O. Barentsz, A. Heerschap. Combined quantitative dynamic contrast-enhanced MR imaging and (1)H MR spectroscopic imaging of human prostate cancer. J Magn Reson Imaging. 2004 Aug;20(2):279-87.

    Kaynak: medipol.com.tr profil sayfası

  43. S. Madersbacher, G. Alivizatos, J. Nordling, C.R. Sanz, M. Emberton, J.J.M.C.H. de la Rosette. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines). Eur Urol. 2004 Nov;46(5):547-54.

    Kaynak: medipol.com.tr profil sayfası

  44. M.C. Michel, J.J.M.C.H. de la Rosette, M. Piro, M. Goepel. Does concomitant stress incontinence alter the efficacy of tolterodine in patients with overactive bladder? J Urol. 2004 Aug;172(2):601-4.

    Kaynak: medipol.com.tr profil sayfası

  45. H. Wijkstra, M.H. Wink, J.J.M.C.H. de la Rosette. Contrast specific imaging in the detection and localization of prostate cancer. World J Urol. 2004; Oct 5.

    Kaynak: medipol.com.tr profil sayfası

  46. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M. Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7

    Kaynak: medipol.com.tr profil sayfası

  47. M. Oelke, J.J.M.C.H. de la Rosette, M.C. Michel, U. Jonas. Medical therapy of urinary incontinence. Internist (Berl). 2004; Dec 18.

    Kaynak: medipol.com.tr profil sayfası

  48. P. Boyle, C. Roehrborn, R. Harkaway, J. Logie, J.J.M.C.H. de la Rosette, M.Emberton. 5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery. Eur Urol. 2004 May; 45(5):620-6; discussion 626-7.

    Kaynak: medipol.com.tr profil sayfası

  49. A. Skolarikos, G. Alivizatos, J.J.M.C.H. de la Rosette. Percutaneous nephrolithotomy and its legacy. Eur. Urol. 2005; 47: 22-28

    Kaynak: medipol.com.tr profil sayfası

  50. M.P. Laguna, L.C. Schreuders, J.J. Rassweiler, C.C. Abbou, R. van Velthoven, G. Janetschek, G. Breda, J.J.M.C.H. de la Rosette. Development of laparoscopic surgery ans training facilities in Europe: Results of a survey of the ESUT. Eur. Urol. 2005; 47: 346-351.

    Kaynak: medipol.com.tr profil sayfası